SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-20-020293
Filing Date
2020-02-13
Accepted
2020-02-13 17:06:29
Documents
2
Group Members
CHRISTOPH KRAIKERDELIA BLEYERJAMES PLEDGERMARC KRIEGSMANNNEXTECH IV GP S.A R.L.NEXTECH IV ONCOLOGY, S.C.S. SICAV-SIFNEXTECH V GP S.A R.L.THOMAS LIPS

Document Format Files

Seq Description Document Type Size
1 SC 13G tm207791d2_sc13g.htm SC 13G 159549
2 EXHIBIT 99.1 tm207791d2_ex99-1.htm EX-99.1 11389
  Complete submission text file 0001104659-20-020293.txt   172823
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Subject) CIK: 0001676725 (see all company filings)

IRS No.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91018 | Film No.: 20611862
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7, RUE LOU HEMMER LUXEMBOURG-FINDEL N4 L-1748
Business Address 7, RUE LOU HEMMER LUXEMBOURG-FINDEL N4 L-1748 352-246-160-6000
Nextech V Oncology S.C.S., SICAV-SIF (Filed by) CIK: 0001712922 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13G